ENDRA Life Sciences (Nasdaq: NDRA)

Medical Equipment Manufacturing • Ann Arbor, Michigan, United States • 21-50 Employees

Company overview

Headquarters	3600 Green Court, Suite 350, Ann Arbor, MI 48105-1570, US
Phone number	+17343350468
Website	endrainc.com
NAICS	3391
SIC	873
Keywords	Medical Devices, Ultrasound, Ultrasound, Medical Imaging, Liver Disease, Nafld
Founded	2009
Employees	21-50
Socials

Key Contacts at ENDRA Life Sciences (Nasdaq: NDRA)

Idan Steinberg

Senior Director Of Research And Development

Scott Sober

Senior Director Of Operations

Christopher Bull

Director Clinical Development

ENDRA Life Sciences (Nasdaq: NDRA) Email Formats

ENDRA Life Sciences (Nasdaq: NDRA) uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@endrainc.com), used 60% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@endrainc.com	60%
{first initial}{last name}	jdoe@endrainc.com	33.3%
{last name}{last name}	doedoe@endrainc.com	6.7%

About ENDRA Life Sciences (Nasdaq: NDRA)

ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA) is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI - at a fraction of the cost, and at the point-of-care. ENDRA's first TAEUS application will focus on the quantification of fat in the liver, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD). ENDRA's goal is to bring new capabilities to ultrasound - thereby broadening access to better healthcare. For more information, please visit www.endrainc.com. Non-Alcoholic Fatty Liver Disease (NAFLD) is a condition closely associated with obesity, diabetes, hepatitis-C and certain genetic predispositions in which fat accumulates in the liver. NAFLD affects over 1 billion people globally and is estimated to cost the U.S healthcare system over $100B annually. NAFLD is often asymptomatic and, If left untreated, NAFLD can progress to inflammation (NASH), tissue scarring (fibrosis), cell death (cirrhosis) and liver cancer. By 2025, NAFLD is forecast to be the greatest root cause of liver transplants. The only tools currently available for diagnosing and monitoring NAFLD are impractical: expensive Magnetic Resonance Imaging (MRI) or an invasive surgical biopsy.

ENDRA Life Sciences (Nasdaq: NDRA) revenue & valuation

Annual revenue	$6,174
Revenue per employee	$1,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$19,756
Total funding	$8,700,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Director

Manager

Employees by Department

ENDRA Life Sciences (Nasdaq: NDRA) has 12 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore ENDRA Life Sciences (Nasdaq: NDRA)'s funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-05-21	14	$8,700,000

Funding Insights

$8,700,000

Total funding amount

$8,700,000

Most recent funding amount

Number of funding rounds

ENDRA Life Sciences (Nasdaq: NDRA) Tech Stack

Discover the technologies and tools that power ENDRA Life Sciences (Nasdaq: NDRA)'s digital infrastructure, from frameworks to analytics platforms.

Leadfeeder

Analytics

Google Workspace

reCAPTCHA

Security

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Nginx

Reverse proxies

PHP

Programming languages

HSTS

Security

Yii

Web frameworks

Open Graph

Miscellaneous

ZURB Foundation

UI frameworks

PWA

Miscellaneous

Frequently asked questions

ENDRA Life Sciences (Nasdaq: NDRA) is located in Ann Arbor, Michigan, US.

You can reach ENDRA Life Sciences (Nasdaq: NDRA) at +17343350468.

ENDRA Life Sciences (Nasdaq: NDRA) was founded in 2009, making it 17 years old. The company has established itself as a significant player in its industry over this time.

ENDRA Life Sciences (Nasdaq: NDRA) has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

ENDRA Life Sciences (Nasdaq: NDRA) has raised a total of $8,700,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.